Salta al contenuto
PodcastScienzePharmaceutical Executive

Pharmaceutical Executive

Pharmaceutical Executive Podcast
Pharmaceutical Executive
Ultimo episodio

407 episodi

  • Pharmaceutical Executive

    Pharmaceutical Executive Daily: FDA Approves Simtriyo

    27/07/2026 | 3 min
    In today's Pharmaceutical Executive Daily, FDA approves Otsuka's Simtriyo as the first NDSRI treatment for ADHD, argenx agrees to acquire Forte Biosciences for approximately $2.2 billion, and an AbbVie neuroscience researcher discusses the shift from symptom management to disease modification in Parkinson's research.
  • Pharmaceutical Executive

    Pharmaceutical Executive Daily: FDA Votes to Reduce Restrictions on Four Peptides

    24/07/2026 | 3 min
    In today's Pharmaceutical Executive Daily, an FDA advisory panel narrowly votes to recommend easing restrictions on four unapproved peptides, a supply chain expert discusses how China's export controls are exposing vulnerabilities in the U.S. pharmaceutical supply chain, and a pharmacy benefits executive lays out a business case for more targeted employer-based GLP-1 coverage.
  • Pharmaceutical Executive

    Pharmaceutical Executive Daily: Eli Lilly Reports Positive Results from Two Phase III Trials

    23/07/2026 | 3 min
    In today's Pharmaceutical Executive Daily, Eli Lilly's Retatrutide delivers up to 22.6% weight loss in two new Phase III trials, a clinical trial expert discusses why the U.S. is losing trial volume to Australia and China, and a pharmacy benefits executive weighs in on why short-term cost thinking is complicating GLP-1 coverage decisions.
  • Pharmaceutical Executive

    Pharmaceutical Executive Daily: Novo Nordisk Files Lawsuit Against Eli Lilly

    22/07/2026 | 2 min
    In today's Pharmaceutical Executive Daily, Novo Nordisk sues Eli Lilly over GLP-1 advertising it calls misleading, President Trump announces a phased tariff plan for imported generic drugs, and a new commentary argues pharma's AI investment is missing the areas of drug discovery where it matters most.
  • Pharmaceutical Executive

    Pharmaceutical Executive Daily: FDA Grants Emergency Use Authorization to Allplex Assay

    21/07/2026 | 3 min
    In today's Pharmaceutical Executive Daily, FDA grants emergency use authorization for Seegene's multiplex PCR assay, a Pfizer medical lead makes the case for continued antiviral use among Covid-19 high-risk patients, and Nuvation Bio's CEO discusses the company's oncology pipeline and philosophy of developing better drugs rather than more of them.
Altri podcast di Scienze
Su Pharmaceutical Executive
The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry. 
Sito web del podcast

Ascolta Pharmaceutical Executive, Ci vuole una scienza e molti altri podcast da tutto il mondo con l’applicazione di radio.it

Scarica l'app gratuita radio.it

  • Salva le radio e i podcast favoriti
  • Streaming via Wi-Fi o Bluetooth
  • Supporta Carplay & Android Auto
  • Molte altre funzioni dell'app